US SB4918 | 2021-2022 | 117th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on September 22 2022 - 25% progression, died in committee
Action: 2022-09-22 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on September 22 2022 - 25% progression, died in committee
Action: 2022-09-22 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the use of patents, trade secrets, or other intellectual property to inhibit competition.
Title
Increasing Prescription Drug Competition Act
Sponsors
| Sen. Margaret Hassan [D-NH] | Sen. Mike Braun [R-IN] |
History
| Date | Chamber | Action |
|---|---|---|
| 2022-09-22 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/senate-bill/4918/all-info |
| Text | https://www.congress.gov/117/bills/s4918/BILLS-117s4918is.pdf |
